Doser is a Netherlands based startup founded in 2018 with the slogan "3D Compounding For Personalized Care". The company offers a modern solution for pharmacists, providing them with the DoseRx1, a desktop-style drug printer that utilizes pharmaceutical 3D printing technology to create personalized dosages tailored to individual patients. This revolutionary compounding system not only facilitates the production of personalized medicines faster and more efficiently, but also eliminates the need for plastics or consumables. Moreover, Doser has established an Ecosystem that allows pharmacists to collaborate on formulation development, exchange cartridges, and produce custom batches for other pharmacies on a local or nationwide scale.
This innovative approach positions Doser at the forefront of the health care and pharmaceutical industries, addressing the growing demand for personalized medication solutions. Although the details of their last investment and the involved investors are currently undisclosed, Doser's unique value proposition and the potential for disruption in the pharmaceutical space present an attractive investment opportunity for venture capitalists looking to support cutting-edge advancements in personalized care.
There is no investment information
No recent news or press coverage available for Doser.